This is an educational work. Thirty patients with pulmonary sarcoidosis will be included in the study and randomly selected into two training groups.One group will receive home inspiratory muscle training (IMT) for 15 minutes, twice a day, 7 days a week with the resh Threshold IMT 'device. In the IMT group, the initial training intensity will be determined by measuring the maximal inspiratory muscle strength (MIP) with the intraoral pressure measuring device, 30% of the measured (MIP) value will be started at the first evaluation and the new training intensity will be determined by calculating 30% of the measured value by repeating the MIP measurement every week. The other group will perform upper extremity and trunk exercises combined with respiratory exercises at home for 7 days, twice a day for 15 minutes.Patients will be evaluated before the training program and 8 weeks after the training. In the first evaluation, demographic information and clinical characteristics of the patients will be noted.In this study, upper and lower extremity exercise capacity, respiratory functions, peripheral muscle strength, dyspnea, fatigue, sleep quality, cognitive function, daily living activities, physical activity level, anxiety, depression, upper extremity and trunk exercises combined with inspiratory muscle training in patients with sarcoidosis and the impact on quality of life.
Patients who are in stage II-III with sarcoidosis diagnosed pulmonary involvement who are admitted to the Department of Chest Diseases of Cerrahpaşa Medical Faculty Hospital of Istanbul University will be included in the 30-70 age group 6 months after systemic treatment or no treatment. Patients with stages I and IV, malignancy, heart failure, orthopedic problems and who have to undergo systemic sarcoidosis treatment during the study will not be included in the study. Thirty-four patients who meet the inclusion criteria will be included in the study by signing the informed consent form. In the first evaluation, demographic information and clinical characteristics of the patients will be noted. Lower and upper extremity functional capacities of the patients before and after training will be evaluated with 6-minute walk test (6MWT), 6-minute step test (6DST), 6-minute pegboard ring test (6DPBRT) and 30-second sit-down test. Percentage values of FVC, FEV1, FEV1 / FVC, PEF, FEF (25-75%) parameters according to measured and expected values will be recorded by performing pulmonary function test. Respiratory muscle strength will be determined by measuring maximal inspiratory pressure (MRP) and maximal expiratory pressure (MEP) with the intraoral pressure gauge. Dyspnea sensation Modified Borg and Modified Medical Research Council (MMRC) scale, fatigue state Fatigue Severity Scale (FSS), peripheral muscle strength hand dynamometer, quality of life George Respiratory Diseases Questionnaire (SGRQ), anxiety and depression status Hospital Anxiety and Depression Scale (HAD), physical activity level International Physical Activity Questionnaire-Short form (IPAQ-S), cognitive function Montreal Cognitive Assessment Scale (MOCA), daily living activities London Chest Daily Living Activities Scale and sleep quality will be evaluated with Epworth Sleepiness Scale (ESS).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
24
7 days a week, 2 times a day 15 min each
upper extremity and trunk exercises combined with breathing exercises for 7 days a week, 2 times a day for 15 minutes each
Esma Yıldız
Edirne, Istanbul, Turkey (Türkiye)
Fatigue severity scale
0-7. high score shows deterioration. \<2,8 no fatigue. \>6,1 chronic fatigue syndrome
Time frame: 8 week
6 minute walk test
Increased walking distance in 6 minutes
Time frame: 8 week
Medical Research Council Dyspnea Scale
0-4. high score shows deterioration
Time frame: 8 week
Respiratory assesment
measure respiratory muscle strength
Time frame: 8 week
Epworth sleepiness scale
0-30. high score shows deterioration
Time frame: 8 week
Hospital Anxiety Scale
anxiety 0-21 .high score shows deterioration
Time frame: 8 week
Hospital Depression Scale
depression 0-21. high score shows deterioration
Time frame: 8 week
Montreal Cognitive Assessment Scale
assess cognitive functions of individuals.0-30. high score indicates improvement
Time frame: 8 week
London Chest Daily Living Activities Scale
Measuring daily living activities. high score shows deterioration. 0-75
Time frame: 8 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.